Cashu
It seems there was an error, as there is no content provided to summarize. Please share the text you'd like me to work with.
2 days ago
Stocks
Health Care
ncna
NuCana plc
NASDAQ: NCNA
-0.00 (0.00%)
0.0425
USD
At close at Aug 08, 20:42 UTC
Overview
Loading chart...
Key Stats
Market Cap
127.04K
Dividend Yield
0.00%
P/E Ratio
-0.00
EPS
-8.39
Revenue
-
Avg. Volume
135.96M
About
What does NCNA do?
NuCana PLC is a UK-based biopharmaceutical company focused on cancer treatments using ProTide technology, with candidates NUC-3373 and NUC-7738 currently in Phase I/II clinical trials. The company's pipeline also includes Acelari, a ProTide transformation of gemcitabine.
Join our newsletter to keep up to date with us!
